Lawrence P. Carter

Alector (United States) — United States

Neuroscience · Life Sciences

23h-index3.0kcitations54works11.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sleep and Wakefulness Research(24), Sleep and related disorders(16), Forensic Toxicology and Drug Analysis(12), Neurotransmitter Receptor Influence on Behavior(9), Restless Legs Syndrome Research(9)

Publications54 total

Phase 1 study of latozinemab in progranulin‐associated frontotemporal dementia
Alzheimer s & Dementia Translational Research & Clinical Interventions·2024· 11 citedOpen Access
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
Neurology and Therapy·2022· 2 citedOpen Access
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial
Human Psychopharmacology Clinical and Experimental·2022· 8 citedOpen Access
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
Human Psychopharmacology Clinical and Experimental·2022· 14 citedOpen Access
A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
Clinical Pharmacology in Drug Development·2020· 5 citedOpen Access
Solriamfétol (JZP-110) pour le traitement de la somnolence diurne excessive (SDE) chez les patients avec narcolepsie avec et sans cataplexie : résultats d’un essai clinique de phase 3 randomisé
Revue Neurologique·2020Open Access
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
CNS Drugs·2020· 17 citedOpen Access
Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial
Annals of the American Thoracic Society·2020· 40 citedOpen Access
Étude randomisée, contrôlée testant le solriamfétol vs placebo dans la somnolence diurne excessive des narcolepsies de type 1 et 2
Médecine du Sommeil·2020
Un essai randomisé contrôlé testant les olriamfétol dans la somnolence diurne excessive des syndromes d’apnées obstructives du sommeil
Médecine du Sommeil·2020
Frontmatter
2019Open Access
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy
Sleep Medicine·2019· 191 cited
P004 Solriamfetol for excessive daytime sleepiness in obstructive sleep apnoea: a randomised controlled trial
Poster presentations·2019· 4 citedOpen Access
P003 Randomised, placebo-controlled study of solriamfetol for excessive daytime sleepiness in narcolepsy types 1/2
Poster presentations·2019Open Access
Pregnancy and Contraception Experiences in Women With Narcolepsy: A Narcolepsy Network Survey
Journal of Clinical Sleep Medicine·2019· 15 citedOpen Access
0618 Weight Change Associated with Solriamfetol Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy or Obstructive Sleep Apnea
SLEEP·2019Open Access
0570 Dose Titration Of Solriamfetol In Participants With Obstructive Sleep Apnea From A 6-week Randomized-withdrawal Trial
SLEEP·2019Open Access
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Annals of Neurology·2019· 318 citedOpen Access
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine·2018· 306 citedOpen Access
Solriamfetol for the Treatment of Excessive Sleepiness in OSA
CHEST Journal·2018· 80 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Roland R. Griffiths(13), Jed Black(12), Geert Mayer(8), Miriam Z. Mintzer(8), Gert Jan Lammers(7), Dan Chen(7), Hélène A. Emsellem(6), Yuan Lü(6), Yves Dauvilliers(5), Russell Rosenberg(5), Atul Malhotra(5), Kingman P. Strohl(5), Todd J. Swick(5), Michael J. Thorpy(5), Lawrence Lee(5), Matthew W. Johnson(5), Michael J. Thorpy(4), Colin M. Shapiro(4), Gary Zammit(4), Mark H. Gotfried(4)